NKILA is considered part of a class of NF-κB modulators that suppress cancer metastasis [26], whereas Huang et al [27] reported that NKILA could sensitize T cells to activation-induced cell death (AICD) which can promote tumor immune evasion. This evidence concerns the gene NFKB1 and cancer.